Turcot syndrome (disorder)
|
0.800 |
GermlineCausalMutation
|
disease |
ORPHANET |
Constitutional mismatch repair-deficiency syndrome.
|
20442441 |
2010 |
Turcot syndrome (disorder)
|
0.800 |
GermlineCausalMutation
|
disease |
ORPHANET |
Simple detection of germline microsatellite instability for diagnosis of constitutional mismatch repair cancer syndrome.
|
23483711 |
2013 |
Turcot syndrome (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Multiple pilomatricomas with somatic CTNNB1 mutations in children with constitutive mismatch repair deficiency.
|
23629955 |
2013 |
Turcot syndrome (disorder)
|
0.800 |
PosttranslationalModification
|
disease |
BEFREE |
Lesions of both sites showed a DNA mismatch repair deficiency with immunohistochemical loss of MLH1 and PMS2 expression without MLH1 promoter hypermethylation.
|
29124495 |
2018 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
CLINGEN |
A homozygous germ-line mutation in the human MSH2 gene predisposes to hematological malignancy and multiple café-au-lait spots.
|
11809679 |
2002 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
BEFREE |
Mismatch repair deficiency is strongly associated with responsiveness to anti-PD-1 in other cancers and can be detected using immunohistochemistry for MLH1, MSH2, MHS6, and PMS2.
|
31702999 |
2020 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
BEFREE |
- Ninety-three colorectal carcinomas with isolated PMS2 loss by immunohistochemistry and 193 with other forms of mismatch repair deficiency were identified.
|
29336605 |
2018 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
CTD_human |
Furthermore, in the family with Turcot syndrome, in which the first inherited PMS2 mutation (R134X) was described, a further truncating mutation was identified on the other allele, in exon 13.
|
15077197 |
2004 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse.
|
16204034 |
2005 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
CTD_human |
Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene.
|
10763829 |
2000 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
BEFREE |
Of note 8/9 (89%) IHC positive cases were both MMRd (all showing MLH1/PMS2 loss) and lacked BRAFV600E mutation.
|
31792356 |
2019 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
CLINGEN |
A homozygous MSH6 mutation in a child with café-au-lait spots, oligodendroglioma and rectal cancer.
|
15340263 |
2004 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
BEFREE |
We propose that staining for PMS2 and MSH6 alone will be sufficient to detect all cases of mismatch repair deficiency and should replace routine screening with all four antibodies.
|
20632815 |
2010 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
PMS2 mutations in childhood cancer.
|
16507833 |
2006 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene.
|
10763829 |
2000 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
BEFREE |
Concerning the background endometrium, two cases showed partial loss of MLH1 and PMS2, corresponding to adjacent EC lesions, suggesting that MMR deficiency may already be present in the background endometrium.
|
31307113 |
2019 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
|
23788249 |
2013 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
BEFREE |
Herein, we investigate the clinical meaning of MMR deficiency in breast cancer by immunohistochemical assessment of MSH2, MSH6, MLH1 and PMS2 on a large series of breast cancers linked to detailed biomarker and long-term outcome data.
|
31522348 |
2020 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Furthermore, we demonstrate, by the analysis of a PMS2/PMS2CL "hybrid" allele carrier, that RNA-based PMS2 testing effectively avoids the caveats of genomic DNA amplification approaches; i.e., pseudogene coamplification as well as allelic dropout, and will, thus, allow more sensitive mutation analysis in MMR deficiency and in HNPCC patients with PMS2 defects.
|
18030674 |
2008 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Germline Genetic Predisposition to Hematologic Malignancy.
|
28297620 |
2017 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Novel biallelic mutations in MSH6 and PMS2 genes: gene conversion as a likely cause of PMS2 gene inactivation.
|
17557300 |
2007 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Café-au-lait spots and early onset colorectal neoplasia: a variant of HNPCC?
|
14574005 |
2001 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair.
|
9500552 |
1998 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Furthermore, in the family with Turcot syndrome, in which the first inherited PMS2 mutation (R134X) was described, a further truncating mutation was identified on the other allele, in exon 13.
|
15077197 |
2004 |